The chart below shows how ADNT performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ADNT sees a +0.99% change in stock price 10 days leading up to the earnings, and a +0.55% change 10 days following the report. On the earnings day itself, the stock moves by -2.17%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Adjusted EBITDA Resilience: Achieved $196 million of adjusted EBITDA, demonstrating resilience despite a 5% year-over-year decline in revenue.
Free Cash Flow Generation: Generated $45 million in free cash flow, reflecting strong cash management and operational efficiency.
Shareholder Return Through Buybacks: Returned $25 million to shareholders through share repurchases in Q1, contributing to a total of $300 million in buybacks for fiscal 2025.
Program Launch Expansion: Launched 16 new programs in Asia during Q1, with over 70 additional programs expected to launch throughout the year, indicating strong growth momentum.
Strong Asia EBITDA Margins: Achieved greater than 14% adjusted EBITDA margins in the Asia segment, showcasing robust profitability despite challenging market conditions.
Negative
EBITDA Decline and Revenue Drop: Adjusted EBITDA decreased by 9% year on year to $196 million, reflecting a $165 million decline in revenue primarily due to lower customer production volumes.
Sales Decline Analysis: Consolidated sales fell to approximately $3.5 billion, down $165 million compared to Q1 fiscal year '24, driven by lower volumes and pricing resulting from customer production declines.
EMEA Volume Impact: In EMEA, weak volume and mix negatively impacted results by $26 million due to lower customer production, despite a slight positive business performance of $2 million.
China Sales Performance Decline: China sales underperformed the overall market, with revenue expected to be flat to slightly declining in fiscal year 2025, primarily due to unfavorable production mix and reduced production targets from luxury and Japanese OEMs.
Sales Outlook Revision: The full year sales outlook was revised down to approximately $13.9 billion, reflecting a $200 million headwind from FX translation and $150 million from lower production levels in Asia and EMEA.
Earnings call transcript: Adient Q1 2025 misses EPS forecast, revenue up
ADNT.N
-1.68%